How to Get Jatenzo in Utah

Utah Telehealth Law and Jatenzo Prescribing

Utah permits telehealth prescribing of Schedule III controlled substances, which includes testosterone products like Jatenzo, provided the prescriber holds an active Utah license or practices under the state's telehealth registration pathway. A synchronous audio-video visit satisfies the standard of care requirement. Utah Code §26-60 governs telehealth practice within the state.

The Endocrine Society's 2018 clinical practice guideline requires documentation of two separate morning serum total testosterone measurements below 300 ng/dL before initiating testosterone therapy 1. Utah-based telehealth providers follow this same threshold. Your provider will order labs through a CLIA-certified facility. Quest Diagnostics and Labcorp both operate draw stations across the Wasatch Front, in St. George, and in Logan.

One practical advantage of telehealth: Utah residents outside the Salt Lake City metro area gain access to endocrinologists and urologists who may not practice in rural counties. Providers on the HealthRX platform can evaluate you remotely, order labs at a facility near your zip code, and transmit the prescription electronically to a Utah-licensed pharmacy.

After the FDA approved Jatenzo in March 2019, the prescribing information specified twice-daily dosing with food, starting at 237 mg orally each morning and evening. Swerdloff et al. confirmed in their key trial (N=166) that 87% of men on the 237 mg starting dose achieved eugonadal testosterone levels (300 to 1 to 100 ng/dL) at day 7, and dose titration brought the overall eugonadal rate to 145 of 166 participants (87.3%) by the end of the study 2.

Who Can Prescribe Jatenzo in Utah

MDs, DOs, nurse practitioners, and physician assistants with prescriptive authority in Utah can all prescribe Schedule III controlled substances, including Jatenzo. Utah's Nurse Practice Act grants NPs independent prescriptive authority after 2 to 000 hours of supervised practice with a collaborating physician.

That distinction matters for access. Rural Utah counties (Daggett, Wayne, Piute) have few or no endocrinologists. NPs and PAs in family medicine or men's health clinics fill that gap. If your provider is unfamiliar with Jatenzo specifically, the Tolmar prescribing portal provides dosing calculators and titration protocols.

Urologists and endocrinologists are the specialists most likely to initiate Jatenzo. The AUA's 2018 guideline on testosterone deficiency recommends specialist referral for men with complicating factors such as a history of prostate cancer, hematocrit above 54%, or untreated severe obstructive sleep apnea 3. If none of those flags apply, a primary care provider can manage the prescription.

Lab Requirements Before Starting Jatenzo in Utah

The lab panel is non-negotiable. Two low morning testosterone readings form the diagnostic foundation. But a responsible provider will order more than just total T.

A standard pre-TRT panel includes total testosterone (drawn between 7 and 10 AM), free testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), complete blood count with hematocrit, comprehensive metabolic panel, lipid panel, and prostate-specific antigen (PSA) for men over 40. The Endocrine Society guideline also recommends a prolactin level if total testosterone is below 150 ng/dL, to rule out pituitary pathology 1.

Why twice? Single measurements can be misleading. Testosterone has a circadian rhythm that peaks in the early morning and drops by 25 to 50% by afternoon. The FDA label for Jatenzo itself specifies that diagnosis should not rest on a single sample.

After starting Jatenzo, follow-up labs are typically drawn at 4 to 6 weeks. The prescribing information recommends checking testosterone trough levels (drawn in the morning before the AM dose) and adjusting the dose in 24.3 mg increments. Hematocrit monitoring is required at 3 to 6 months and then annually, per the Endocrine Society guideline 1. If hematocrit exceeds 54%, the provider must reduce the dose or discontinue therapy.

Utah Pharmacy Options: Brand Jatenzo vs. 503A Compounding

Brand Jatenzo is stocked by major retail and specialty pharmacies in Utah. CVS, Walgreens, and the University of Utah Health pharmacy system all carry it or can order it within 1 to 3 business days. Specialty pharmacies like Optum Rx and Accredo handle Jatenzo fulfillment for plans that require specialty distribution.

Utah also licenses 503A compounding pharmacies under the Utah Department of Commerce, Division of Occupational and Professional Licensing (DOPL). These pharmacies can compound oral testosterone undecanoate capsules based on a patient-specific prescription. The compounded version is not Jatenzo (a branded product with a specific formulation using the Self-Emulsifying Drug Delivery System, or SEDDS technology), but it contains the same active ingredient.

Price drives many patients toward compounding. Brand Jatenzo carries a wholesale acquisition cost (WAC) of roughly $650 to $750 per month. Compounded oral testosterone undecanoate from a Utah 503A pharmacy typically runs $90 to $200 per month out of pocket. The tradeoff: compounded products do not undergo FDA bioequivalence testing, and absorption may differ from the branded formulation. A 2021 commentary in the Journal of Clinical Endocrinology & Metabolism noted that SEDDS-based oral testosterone undecanoate (the Jatenzo formulation) achieved more consistent lymphatic absorption compared to earlier oil-based capsules 4.

Mail-order pharmacy is another pathway. Utah does not prohibit the receipt of Schedule III prescriptions by mail from a licensed pharmacy. Telehealth providers commonly pair with mail-order pharmacies that ship directly to the patient's address, cutting out the in-person pharmacy visit entirely.

Insurance Coverage and Prior Authorization in Utah

Most commercial insurers in Utah cover Jatenzo on a specialty or non-preferred brand tier, but virtually all require prior authorization. Here is what that process looks like.

Your prescriber submits documentation including the two qualifying testosterone levels, confirmation that the patient has signs or symptoms of hypogonadism, and evidence that there is a clinical reason to choose oral therapy over injectable testosterone cypionate (which is far cheaper at $30 to $60 per month for the generic). Insurers want to know why the oral route is medically necessary. Documented reasons that succeed: needle phobia with objective documentation, history of injection-site reactions, impaired dexterity or mobility that prevents self-injection, or occupational constraints (e.g., commercial driver medical certification requirements where injection-related hematoma poses a risk).

SelectHealth, the dominant commercial insurer along the Wasatch Front, lists Jatenzo on its specialty formulary with step therapy requiring prior failure of or contraindication to injectable testosterone. PEHP (Public Employees Health Plan) follows a similar policy. University of Utah Health Plans applies its own PA criteria, which align with the Endocrine Society guideline thresholds.

Utah Medicaid (administered by the Utah Department of Health & Human Services) does not currently cover brand-name Jatenzo for male hypogonadism. Medicaid beneficiaries seeking oral testosterone therapy may explore the compounded route through a 503A pharmacy, but coverage for compounded medications varies by managed care organization. Molina Healthcare of Utah and SelectHealth Community Care (the two primary Medicaid MCOs) each have separate compounding policies.

Tolmar offers a manufacturer copay savings card that reduces the out-of-pocket cost to as low as $0 per month for commercially insured patients, subject to a maximum annual benefit. This card cannot be used with Medicaid, Medicare, or other federal healthcare programs per the federal Anti-Kickback Statute 5.

Transferring a Jatenzo Prescription to Utah

If you are relocating to Utah from another state, your existing Jatenzo prescription can be transferred to a Utah-licensed pharmacy. Utah follows the standard DEA transfer rules for Schedule III through V substances: the prescription can be transferred once between pharmacies, and both the sending and receiving pharmacist must document the transfer in their records.

A simpler path: ask your current provider to send a new electronic prescription directly to a Utah pharmacy. If your provider is not licensed in Utah, you will need to establish care with a Utah-licensed prescriber. Telehealth makes this fast. A new-patient visit to verify your existing labs, review your dosing history, and issue a fresh prescription typically takes 15 to 30 minutes.

Utah does not impose a waiting period for new residents to fill controlled substance prescriptions. As long as your prescription originates from a provider licensed in Utah (or a provider in a state with a valid telehealth compact agreement), any Utah pharmacy can dispense it immediately.

Timeline: How Long Until You Receive Jatenzo in Utah

The total elapsed time from initial consultation to first dose depends on three variables: lab turnaround, insurance authorization, and pharmacy fulfillment.

Lab turnaround is typically 2 to 3 business days through Quest or Labcorp in Utah. If your provider accepts outside labs, prior results less than 6 months old may satisfy the diagnostic requirement without a new draw. That saves a week.

Prior authorization decisions in Utah must be made within 72 hours for non-urgent requests under Utah Insurance Code §31A-22-649. Many insurers respond within 24 to 48 hours electronically. If denied, the prescriber can file a peer-to-peer review or appeal. Appeals add 7 to 14 days.

Pharmacy fulfillment for brand Jatenzo takes 1 to 3 business days at retail pharmacies and 3 to 7 business days through specialty mail-order. Compounded oral testosterone undecanoate from a Utah 503A pharmacy typically ships within 5 to 10 business days, as each batch is made to order.

Best case, if you already have qualifying labs and the insurer approves quickly: 4 to 5 days from telehealth visit to capsules in hand. Typical case with new labs and standard PA processing: 10 to 14 days.

Blood Pressure Monitoring and Cardiovascular Considerations

Jatenzo carries an FDA boxed warning for blood pressure increases. In the Swerdloff et al. trial, systolic blood pressure increased by a mean of 3 to 5 mmHg, and 7.2% of participants developed new-onset hypertension during the 12-month study period 2. The FDA requires prescribers to monitor blood pressure at baseline, at the first follow-up visit, and periodically thereafter.

The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, provided reassurance on the broader cardiovascular safety question. Among men ages 45 to 80 with hypogonadism and pre-existing cardiovascular disease or high cardiovascular risk, transdermal testosterone did not increase the incidence of major adverse cardiovascular events compared to placebo over a mean follow-up of 33 months 6. TRAVERSE used transdermal gel rather than oral testosterone undecanoate, so direct extrapolation to Jatenzo requires caution. Still, the trial shifted the field's risk calculus.

Dr. Shalender Bhasin, principal investigator of TRAVERSE, stated: "The results provide the most definitive evidence to date that testosterone replacement therapy in men with hypogonadism and cardiovascular risk factors does not increase the short- to medium-term risk of major adverse cardiac events" 6.

Utah providers should still screen for uncontrolled hypertension before initiating Jatenzo. The American College of Cardiology defines uncontrolled hypertension as sustained readings above 140/90 mmHg 7. Patients with blood pressure in that range need optimization before starting oral testosterone.

Dose Titration and Follow-Up Protocol

The starting dose is 237 mg twice daily with food. Fat content in the meal matters. The FDA label specifies that Jatenzo should be taken with food to ensure adequate absorption via the intestinal lymphatic system. A meal containing at least 15 to 20 grams of fat optimizes this pathway.

At the 4- to 6-week follow-up, the prescriber checks a trough total testosterone (drawn before the morning dose). If the level falls below 300 ng/dL, the dose increases to 316 mg twice daily. If it exceeds 1 to 100 ng/dL, the dose decreases to 158 mg twice daily. The Endocrine Society recommends maintaining testosterone within the 450 to 600 ng/dL range for optimal symptom relief while minimizing erythrocytosis risk 1.

Long-term monitoring includes hematocrit every 6 to 12 months, lipid panels annually, and PSA annually for men over 40. Dr. Abraham Morgentaler, a urologist at Harvard Medical School and author of the 2016 Endocrine Society white paper on testosterone therapy safety, has emphasized: "The greatest risk of testosterone therapy is not starting it in men who need it, but failing to monitor properly once treatment begins" 8.